| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Perry Moore, Abigail Methley, Catherine Pollard, Kerry Mutch, Shahd Hamid, Liene Elsone, Anu Jaco. Cognitive and psychiatric comorbidities in neuromyelitis optica. Journal of the neurological sciences. vol 360. 2016-10-05. PMID:26723962. |
our primary objective was to examine the neuropsychological and psychopathological profile of patients with neuromyelitis optica (nmo) and compare these to multiple sclerosis (ms) and healthy control (hc) groups. |
2016-10-05 |
2023-08-13 |
Not clear |
| Praveena Manogaran, Irene Vavasour, Michael Borich, Shannon H Kolind, Alex P Lange, Alexander Rauscher, Lara Boyd, David Kb Li, Anthony Traboulse. Corticospinal tract integrity measured using transcranial magnetic stimulation and magnetic resonance imaging in neuromyelitis optica and multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England). vol 22. issue 1. 2016-09-27. PMID:25948623. |
both multiple sclerosis (ms) and neuromyelitis optica (nmo) can present with transverse myelitis; however, nmo symptoms are usually more severe and may present with more extensive axonal loss. |
2016-09-27 |
2023-08-13 |
Not clear |
| Manki Son, Daesan Kim, Kyung Seok Park, Seunghun Hong, Tai Hyun Par. Detection of aquaporin-4 antibody using aquaporin-4 extracellular loop-based carbon nanotube biosensor for the diagnosis of neuromyelitis optica. Biosensors & bioelectronics. vol 78. 2016-09-26. PMID:26594890. |
neuromyelitis optica (nmo) is a rare disease of the central nerve system that affects the optic nerves and the spinal cord. |
2016-09-26 |
2023-08-13 |
human |
| Patrick Yu-Wai-Man, Achillefs Spyropoulos, Holly J Duncan, Joseph V Guadagno, Patrick F Chinner. A multiple sclerosis-like disorder in patients with OPA1 mutations. Annals of clinical and translational neurology. vol 3. issue 9. 2016-09-22. PMID:27656661. |
although the neurological phenotype resembled neuromyelitis optica (nmo), anti-aquaporin 4 antibodies were not detected and the disorder followed a slow progressive course. |
2016-09-22 |
2023-08-13 |
Not clear |
| Larry Steinman, Amit Bar-Or, Jacinta M Behne, Daniel Benitez-Ribas, Peter S Chin, Michael Clare-Salzler, Donald Healey, James I Kim, David M Kranz, Andreas Lutterotti, Roland Martin, Sven Schippling, Pablo Villoslada, Cheng-Hong Wei, Howard L Weiner, Scott S Zamvil, Michael R Yeaman, Terry J Smit. Restoring immune tolerance in neuromyelitis optica: Part I. Neurology(R) neuroimmunology & neuroinflammation. vol 3. issue 5. 2016-09-20. PMID:27648463. |
restoring immune tolerance in neuromyelitis optica: part i. neuromyelitis optica (nmo) and spectrum disorder (nmo/sd) represent a vexing process and its clinical variants appear to have at their pathogenic core the loss of immune tolerance to the aquaporin-4 water channel protein. |
2016-09-20 |
2023-08-13 |
human |
| H Masuda, M Mori, A Uzawa, M Muto, T Uchida, S Kuwabar. Serum antinuclear antibody may be associated with less severe disease activity in neuromyelitis optica. European journal of neurology. vol 23. issue 2. 2016-09-15. PMID:25903772. |
the aim of this study was to compare clinical and laboratory features between ms and neuromyelitis optica (nmo) patients with and without autoantibodies and to investigate the prognosis of nmo in patients with and without autoantibodies. |
2016-09-15 |
2023-08-13 |
Not clear |
| Minshu Li, Yaping Ya. Experimental models of neuromyelitis optica: current status, challenges and future directions. Neuroscience bulletin. vol 31. issue 6. 2016-09-15. PMID:26109280. |
neuromyelitis optica (nmo) is a recurrent inflammatory disease that predominantly attacks the opticnerves and spinal cord. |
2016-09-15 |
2023-08-13 |
Not clear |
| S Jarius, B Wildeman. Devic's disease before Devic: Bilateral optic neuritis and simultaneous myelitis in a young woman (1874). Journal of the neurological sciences. vol 358. issue 1-2. 2016-09-15. PMID:26303625. |
neuromyelitis optica (nmo, devic's disease) is an often severely disabling disorder of the central nervous system (cns) which mainly affects the optic nerves and spinal cord. |
2016-09-15 |
2023-08-13 |
Not clear |
| DeRen Huan. Challenges in randomized controlled trials and emerging multiple sclerosis therapeutics. Neuroscience bulletin. vol 31. issue 6. 2016-09-15. PMID:26480875. |
recent studies using the mcdonald ms diagnostic criteria carefully excluded patients with neuromyelitis optica (nmo) and nmo spectrum disorder, and demonstrated that patients with ms in asia have clinical characteristics and treatment responses similar to those in western countries. |
2016-09-15 |
2023-08-13 |
human |
| Masahiko Watanabe, Kentaro Furusho, Toshiyuki Takahashi, Akira Tamaok. Galactorrhea in a Patient With Aquaporin-4 Antibody-positive Neuromyelitis Optica Spectrum Disorder: A Case Report and Review of the Literature. The neurologist. vol 20. issue 6. 2016-09-15. PMID:26671741. |
the hypothalamus is becoming known as an area highly expressing aquaporin-4 and frequently involved in intracranial lesions of patients with neuromyelitis optica (nmo). |
2016-09-15 |
2023-08-13 |
Not clear |
| Kavitha Kothur, Louise Wienholt, Fabienne Brilot, Russell C Dal. CSF cytokines/chemokines as biomarkers in neuroinflammatory CNS disorders: A systematic review. Cytokine. vol 77. 2016-09-14. PMID:26463515. |
th2 and th17 cytokines are frequently elevated in acute disseminated encephalomyelitis (adem) and neuromyelitis optica (nmo), whereas th1 and th17 cytokines are more commonly elevated in multiple sclerosis (ms). |
2016-09-14 |
2023-08-13 |
Not clear |
| Ana Teresa Nunes, Ana Cláudia Fonseca, Filomena Pint. Devic's syndrome in aquaporin-4 antibody negative patient. What we need to know …. GMS ophthalmology cases. vol 4. 2016-09-14. PMID:27625944. |
neuromyelitis optica (nmo) is a severe demyelinating syndrome characterized by optic neuritis (on) and acute myelitis. |
2016-09-14 |
2023-08-13 |
Not clear |
| Ana Teresa Nunes, Ana Cláudia Fonseca, Filomena Pint. Devic's syndrome in aquaporin-4 antibody negative patient. What we need to know …. GMS ophthalmology cases. vol 4. 2016-09-14. PMID:27625944. |
nmo was previously assumed to be a variant of multiple sclerosis (ms), but the discovery of aquaporin-4 antibodies in patients with neuromyelitis optica has led to this view being revised (mandler 2006, barnett/sutton 2012, wingerchuk et al. |
2016-09-14 |
2023-08-13 |
Not clear |
| S Jarius, O Aktas, B Wildeman. Gamma-aminobutyric acid receptor agonists, aquaporin-4, and neuromyelitis optica: a potential link. Medical hypotheses. vol 85. issue 5. 2016-09-09. PMID:26323247. |
neuromyelitis optica (nmo; also termed devic's disease) is a severely disabling autoimmune disorder of the central nervous system (cns), which predominantly affects the optic nerves and spinal cord. |
2016-09-09 |
2023-08-13 |
Not clear |
| N Zhang, Y J Li, Y Fu, J H Shao, L L Luo, L Yang, F D Shi, Y Li. Cognitive impairment in Chinese neuromyelitis optica. Multiple sclerosis (Houndmills, Basingstoke, England). vol 21. issue 14. 2016-09-06. PMID:25828756. |
cognitive dysfunction is frequently seen in neuromyelitis optica (nmo). |
2016-09-06 |
2023-08-13 |
Not clear |
| Masakazu Nakamura, Manabu Araki, Takashi Yamamur. [Plasmablast in the pathology of multiple sclerosis]. Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology. vol 38. issue 5. 2016-09-01. PMID:26725862. |
interestingly, an ms-like autoimmune disease neuromyelitis optica (nmo) is exclusively resistant to this therapy and mediated by il-6-dependnet pbs via producing a disease-specific autoantibody against aquaporin 4 (aqp4) on astrocyte. |
2016-09-01 |
2023-08-13 |
Not clear |
| Takeshi Ushigusa, Kunihiro Ichinose, Shuntaro Sato, Toru Michitsuji, Toshimasa Shimizu, Masataka Umeda, Shoichi Fukui, Ayako Nishino, Yoshikazu Nakashima, Tomohiro Koga, Shin-ya Kawashiri, Naoki Iwamoto, Yasuko Hirai, Mami Tamai, Hideki Nakamura, Tomoki Origuchi, Atsushi Kawakam. Soluble α-klotho is a potential biomarker associated with neuropsychiatric systemic lupus erythematosus. Clinical immunology (Orlando, Fla.). vol 165. 2016-08-31. PMID:26960950. |
patients with sle without neuropsychiatric manifestations (sle) (n=25), and patients with viral meningitis (vm) (n=19), multiple sclerosis (ms) (n=20) or neuromyelitis optica (nmo) (n=20) were included as controls. |
2016-08-31 |
2023-08-13 |
Not clear |
| Rosamond Rhode. A placebo controlled trial for an NMO relapse prevention treatment: Ethical considerations. Multiple sclerosis and related disorders. vol 4. issue 6. 2016-08-26. PMID:26590665. |
this paper addresses the ethical acceptability of a proposed placebo controlled trial of a new intervention as a possible relapse prevention treatment for neuromyelitis optica (nmo). |
2016-08-26 |
2023-08-13 |
human |
| Kerry Mutch, Sizheng Zhao, Shahd Hamid, Abigail Methley, Liene Elsone, Gurpreet Singh, Carolyn Young, Anton Emmanuel, Jalesh Panicker, Anu Jaco. Bladder and bowel dysfunction affect quality of life. A cross sectional study of 60 patients with aquaporin-4 antibody positive Neuromyelitis Optica spectrum disorder. Multiple sclerosis and related disorders. vol 4. issue 6. 2016-08-26. PMID:26590671. |
transverse myelitis (tm) associated with neuromyelitis optica (nmo) can be severe and is well known to reduce mobility early in the disease. |
2016-08-26 |
2023-08-13 |
Not clear |
| Bleranda Zeka, Maria Hastermann, Sonja Hochmeister, Nikolaus Kögl, Nathalie Kaufmann, Kathrin Schanda, Simone Mader, Tatsuro Misu, Paulus Rommer, Kazuo Fujihara, Zsolt Illes, Fritz Leutmezer, Douglas Kazutoshi Sato, Ichiro Nakashima, Markus Reindl, Hans Lassmann, Monika Brad. Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS. Acta neuropathologica. vol 130. issue 6. 2016-08-24. PMID:26530185. |
in neuromyelitis optica (nmo), astrocytes become targets for pathogenic aquaporin 4 (aqp4)-specific antibodies which gain access to the central nervous system (cns) in the course of inflammatory processes. |
2016-08-24 |
2023-08-13 |
rat |